78 related articles for article (PubMed ID: 10798522)
21. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
[TBL] [Abstract][Full Text] [Related]
22. 3D-QSAR study of corticotropin-releasing factor 1 antagonists and pharmacophore-based drug design.
Ye Y; Liao Q; Wei J; Gao Q
Neurochem Int; 2010 Jan; 56(1):107-17. PubMed ID: 19782115
[TBL] [Abstract][Full Text] [Related]
23. The multiplicity of actions of benzodiazepine receptor ligands.
Haefely WE; Martin JR; Richards JG; Schoch P
Can J Psychiatry; 1993 Nov; 38 Suppl 4():S102-8. PubMed ID: 8306240
[TBL] [Abstract][Full Text] [Related]
24. Local intersection volume: a new 3D descriptor applied to develop a 3D-QSAR pharmacophore model for benzodiazepine receptor ligands.
Verli H; Albuquerque MG; Bicca de Alencastro R; Barreiro EJ
Eur J Med Chem; 2002 Mar; 37(3):219-29. PubMed ID: 11900866
[TBL] [Abstract][Full Text] [Related]
25. New 1,5-benzodiazepine compounds: activity at native GABA(A) receptors.
Gatta E; Cupello A; Di Braccio M; Grossi G; Ferruzzi R; Roma G; Robello M
Neuroscience; 2010 Mar; 166(3):917-23. PubMed ID: 20096335
[TBL] [Abstract][Full Text] [Related]
26. Comparison of benzodiazepine-like compounds using topological analysis and genetic algorithms.
Meurice N; Leherte L; Vercauteren DP
SAR QSAR Environ Res; 1998; 8(3-4):195-232. PubMed ID: 9522475
[TBL] [Abstract][Full Text] [Related]
27. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
Axe FU; Bembenek SD; Szalma S
J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
[TBL] [Abstract][Full Text] [Related]
28. Studies of molecular pharmacophore/receptor models for GABAA/benzodiazepine receptor subtypes: binding affinities of substituted beta-carbolines at recombinant alpha x beta 3 gamma 2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis.
Huang Q; Cox ED; Gan T; Ma C; Bennett DW; McKernan RM; Cook JM
Drug Des Discov; 1999 Jul; 16(1):55-76. PubMed ID: 10466057
[TBL] [Abstract][Full Text] [Related]
29. 3D-pharmacophores of flavonoid binding at the benzodiazepine GABA(A) receptor site using 4D-QSAR analysis.
Hong X; Hopfinger AJ
J Chem Inf Comput Sci; 2003; 43(1):324-36. PubMed ID: 12546568
[TBL] [Abstract][Full Text] [Related]
30. 3D-Quantitative structure-activity relationship and docking studies of the tachykinin NK3 receptor.
Geldenhuys WJ; Simmons MA
Bioorg Med Chem Lett; 2011 Dec; 21(24):7405-11. PubMed ID: 22056747
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma(1) receptor ligands based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives.
Zampieri D; Mamolo MG; Laurini E; Florio C; Zanette C; Fermeglia M; Posocco P; Paneni MS; Pricl S; Vio L
J Med Chem; 2009 Sep; 52(17):5380-93. PubMed ID: 19673530
[TBL] [Abstract][Full Text] [Related]
32. Pharmacophore-based molecular docking to account for ligand flexibility.
Joseph-McCarthy D; Thomas BE; Belmarsh M; Moustakas D; Alvarez JC
Proteins; 2003 May; 51(2):172-88. PubMed ID: 12660987
[TBL] [Abstract][Full Text] [Related]
33. Putative benzodiazepine partial agonists demonstrate receptor heterogeneity.
Chen SW; Chen HA; Davies MF; Loew GH
Pharmacol Biochem Behav; 1996 Jan; 53(1):87-97. PubMed ID: 8848465
[TBL] [Abstract][Full Text] [Related]
34. A structure-based QSAR and docking study on imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4,]benzodiazepines as Selective GABA(A) α5 inverse agonists.
Gharaghani S; Khayamian T; Keshavarz F
Chem Biol Drug Des; 2011 Oct; 78(4):612-21. PubMed ID: 21756285
[TBL] [Abstract][Full Text] [Related]
35. A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands.
Shenderovich MD; Liao S; Qian X; Hruby VJ
Biopolymers; 2000 Jun; 53(7):565-80. PubMed ID: 10766952
[TBL] [Abstract][Full Text] [Related]
36. Pruned receptor surface models and pharmacophores for three-dimensional database searching.
Sutherland JJ; O'Brien LA; Weaver DF
J Med Chem; 2004 Jul; 47(15):3777-87. PubMed ID: 15239656
[TBL] [Abstract][Full Text] [Related]
37. Synthetic and computer assisted analysis of the pharmacophore for agonists at benzodiazepine receptors.
Diaz-Arauzo H; Koehler KF; Hagen TJ; Cook JM
Life Sci; 1991; 49(3):207-16. PubMed ID: 1648158
[TBL] [Abstract][Full Text] [Related]
38. 3-Alkyl- and 3-amido-isothiazoloquinolin-4-ones as ligands for the benzodiazepine site of GABA(A) receptors.
Nilsson J; Østergaard Nielsen E; Liljefors T; Nielsen M; Sterner O
Bioorg Chem; 2012 Feb; 40(1):125-130. PubMed ID: 22055239
[TBL] [Abstract][Full Text] [Related]
39. Seeking potential anticonvulsant agents that target GABAA receptors using experimental and theoretical procedures.
Saavedra-Vélez MV; Correa-Basurto J; Matus MH; Gasca-Pérez E; Bello M; Cuevas-Hernández R; García-Rodríguez RV; Trujillo-Ferrara J; Ramos-Morales FR
J Comput Aided Mol Des; 2014 Dec; 28(12):1217-32. PubMed ID: 25298123
[TBL] [Abstract][Full Text] [Related]
40. The active analog approach applied to the pharmacophore identification of benzodiazepine receptor ligands.
Tebib S; Bourguignon JJ; Wermuth CG
J Comput Aided Mol Des; 1987 Jul; 1(2):153-70. PubMed ID: 2848099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
